Skip to main content
. 2014 Nov;50(16):2763–2770. doi: 10.1016/j.ejca.2014.08.002

Table 5.

Factors influencing chemotherapy prescribing overall.

Factor Significance OR
Interval <0.001
 Oncotype available on trial only 0.049 0.49
 Oncotype not publicly reimbursed 0.022 0.37
 Oncotype routinely used <0.001 0.20



Grade <0.001
 Grade 2 <0.001 5.37
 Grade 3 <0.001 7.40



Size 0.029 1.03
Age <0.001 0.91

Compared to interval prior to availability of Oncotype DX.

Compared to grade I.